GLP1R and peripheral arterial disease: Moving forward, several studies (e.g., STRIDE, STARDUST, LEADPACE) are set to expand upon this area of knowledge by investigating how GLP-1 RAs may affect functional movement and peripheral endothelial function in patients with PAD (Table 3).